For all the extraordinary innovations made in the field of medical science, in many ways we are still working in the dark. Take renal transplants. When it comes to selecting kidneys for transplantation, the status quo is an unsatisfactory compromise based largely on a hopeful assumption as to the health of the donated organ – primarily based on the age of the donor – with very little empirical evidence. If the status quo can be improved, in this one field out of many, there are priceless potential benefits to patients and healthcare systems everywhere. Simon Tilley at SAS discusses the collaborative partnership between SAS & The University of Cambridge for identifying ways in which the process of selecting kidneys for transplantation could be better delivered through AI-augmented interpretation of renal biopsies.